Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 8,256 shares at $23.27 ($192K) on 2026-05-04, disclosed to the SEC on 2026-05-06.
Scheduled sale ($192k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.27 | 7,372 | $172K | 89.2% |
| 2 | $23.61 | 884 | $21K | 10.8% |
| Total | $23.31 avg | 8,256 | $192K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |
| ARQT | SELL | 2026-02-04 | $1.2M | — | Filing → |